13th Feb 2009 10:38
Consort Medical plc
Appointment of new Chairman
The Board is delighted to announce the appointment of Dr Peter Fellner as Chairman of Consort Medical as of May 1 2009. Peter will succeed John Robinson who has been Chairman for more than five years.
Peter Fellner was appointed a non-executive director of Consort Medical in November 2005 and is currently the senior independent director and Chair of the Remuneration Committee. He becomes Deputy Chairman as at today's date.
Dr Fellner is Chairman of Vernalis PLC and Astex Therapeutics Ltd, and a non-executive director of UCB S.A., QinetiQ Group plc and Evotec AG. He also chaired Acambis plc from 2006 to September 2008, until its acquisition by Sanofi Aventis for £280 million.
Prior to this Peter served as Chief Executive Officer of Celltech Group PLC from 1990 to 2003 and as Chairman from 2003 until its acquisition for £1.53 billion in 2004. Dr Fellner joined Celltech from Roche UK, where he served as Chief Executive Officer from 1986 to 1990.
John Robinson, Chairman of Consort Medical commented:
"Peter has significant experience to offer both the executive management team and the shareholders of Consort Medical as it continues on its strategy of becoming a leading provider of medical devices. I am delighted that he has agreed to become Chairman."
Peter Fellner commented:
"Consort Medical has considerable potential for growth. I would like to thank John for his leadership over the past five years and I greatly look forward to my new role as Chairman."
There are no further details requiring disclosure under Listing Rule 9.6.11
For further information, please contact:
|
Consort Medical plc |
|
|
Jon Glenn |
Tel: +44 (0) 1442 867920 |
|
Maitland |
|
|
Liz Morley |
Tel: +44 (0) 20 7379 5151 |
Consort Medical plc is a leader in medical devices for inhaled drug delivery and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.
Consort Medical develops and manufactures metered dose inhaler valves, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn and Hemel Hempstead in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai, India. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).
Related Shares:
CSRT.L